Abstract The incidence of candidemia and invasive candidiasis have increased markedly due to the increasing number of immunocompromised patients.
Introduction
The Candida species may cause a wide variety of diseases in human, ranging from oral thrush to disseminated invasive diseases. The United States National Nosocomial Infections Surveillance (NNIS) System had documented that Candida species could be isolated from multiple clinical sites, including bloodstream, surgical wound, lower respiratory and urinary tract. The causes of invasive candidiasis had been determined including the use of intravascular devices, antimicrobial receipt and prolonged hospitalization.
In 2003, Yang et al. had studied the prevalence of different Candida species from three hospitals in Singapore [1] . This study had reported Candida albicans was the predominant species (33.3%) isolated from bloodstream infections patients, followed by Candida tropicalis (22.2%), Candida parapsilosis (19.4%), Candida glabrata (15.3%) and Candida krusei (2.7%). Martin et. al. had done a retrospective study from 1998 to 2001, to determine the types of Candida species isolated from bloodstream cultures in Lyon, France [2] . C. albicans was found to be the leading cause of Candida infection (49.5%), followed by C. glabrata (12.6%) and C. parapsilosis (12.1%) while among the oncohaematology patients, the major cause of candidemia was C. krusei (34%), followed by C. albicans (19%). A population-based active laboratory surveillance to determine the incidence of Candida bloodstream infection was conducted in U.S. from 1998 to 2000 in Baltimore, and the state of Connecticut by Rana et al. 2004 [3] . Among 935 Candida isolates, C. albicans comprised 45%, followed by C. glabrata (24%), C. parapsilosis (13%), C. tropicalis (12%), C. krusei (2.1%), Candida lusitaniae (1.6%), Candida dubliniensis (0.9%), Candida kefyr and Candida rugosa (both 0.1%).
In Malaysia, two studies had been conducted by Ng et al. in 1999 and 2000 [4, 5] . C. albicans (44.2%) appeared to be the most prevalent Candida species isolated from the clinical specimens, followed by C. parapsilosis (26.0%), C. tropicalis (17.7%), C. glabrata (9.6%), C. krusei (1.25%), Candida rugosa (0.62%), Candida guilliermondii (0.26%) and Candida lusitaniae (0.08%).
Routinely, the laboratory diagnosis of candidemia or systemic candidiasis requires the isolation of Candida by mycological culture followed by identification to species level using morphological characteristics and various biochemical-based sugar fermentation tests such as the API-20C commercial strip (Bio-Meriux, France). Unfortunately, the interpretation of these test results requires skilled mycologists.
Here, we report the isolation and molecular identification of an uncommon strain of Candida, Candida orthopsilosis, from the blood of a patient in an oncology ward. To the best of the authors' knowledge, this is the first report of a C. orthopsilosis clinical strain isolated from the Asian region.
Materials and Methods

Fungal Isolate
The Candida isolates were obtained from two blood culture specimens taken with an interval of 4 days from a patient who had acute lymphoblastic leukaemia. She was febrile and had a chemoport catheter inserted when blood culture specimens were collected. The specimens were processed using BacTec 9120 (Becton Dickinson Sparks, MD) at a private hospital in Kuala Lumpur. Candida species were isolated from the specimens and sent to the Department of Biomedical Sciences, University Putra Malaysia for further identification.
Culture and Biochemical Tests
The isolates were cultured on Sabouraud Dextrose Agar (SDA) (Oxoid, Hamptonshire, England) at 37°C and 42°C for 24-48 h. Colony morphology was observed and recorded. For identification of the yeast, API ID 32C (bioMérieux, France) was used which is based on the capability of different species of Candida to assimilate different sources of carbohydrates.
DNA Extraction
A colony of the Candida species was picked and inoculated in 10 ml Sabouraud Dextrose broth (SDB) and incubated for 24 h. About 1 ml of SDB containing Candida culture was harvested via centrifugation. The cell pellet was resuspended in 500 ll lysis buffer (50 mM Tris-HCl pH7.5, 10 mM EDTA) and incubated at 37°C for 1 h. Proteinase K and SDS were added to a final concentration of 1% v/v and 0.4 mg/ml and the mixture was incubated at 56°C for 1 h. Following centrifugation at 13,200 rpm for 3 min, the supernatant was removed and 300 ll of Nuclei Lysis Solution (Wizard DNA purification kit, Promega) was added to the pellet and mixed gently. The subsequent procedures were carried out according the manufacturer's instructions. Finally, the DNA pellet was rehydrated overnight in 30 ll of DNA Rehydration Solution (as specified by the kit) and added with 1.5 ll of RNAse Solution to degrade the existing RNA.
Polymerase Chain Reaction
The primers used for universal fungal amplification were ITS 1 (forward primer) [5 0 -TCC GTA GGT GAA CCT GCC-3 0 ] and ITS 4 (reverse primer) [5 0 -TCC TCC GCT TAT TGA TAT GC-3 0 ]. These primers amplify the intervening 5.8S ribosomal DNA (rDNA) and the adjacent internal transcribed spacer 1 (ITS 1) and ITS 2 regions of fungi. Each PCR reaction with total volume of 20 ll contained 20 ng of template DNA, with the final concentration of reagents as follows: 1X PCR buffer, 2 mM MgCl2, 0.2 mM each dNTPs, 10 pmol each of forward and reverse primers, Taq polymerase (1U) and an appropriate volume of autoclaved Millipore water to adjust to the final volume. Amplifications were carried out in a thermocycler (MJ Research) at conditions of one cycle at 95°C for 5 min, followed by 30 cycles of 95°C for 20 s, 55°C for 15 s, 72°C for 65 s and final extension at 72°C for 10 min. About 5 ll of the PCR products were run on a 1.5% agarose gel containing 0.5 ll ethidium bromide (10 mg/ml, Biorad, USA) and viewed using the AlphaImager (Alpha Innotech, USA) and the electrophoretic pattern captured digitally.
DNA Sequencing and Analysis
The PCR products were diluted 20-fold, and re-amplified using the same primers in five separate tubes to increase the yield for DNA sequencing purpose. The amplicons were subjected to gel electrophoresis as above and the bands containing the desired amplicon were excised from the gel. The PCR products were gel-purified using the Qiaex gel purification column kit (Qiagen, Germany) following the manufacturer's instruction manual. Purified PCR products were then subjected to automated fluorescent sequencing using the ABI-PRISM BigDye Dideoxy Terminator Reagents and the ABI 377 DNA sequencer. The DNA sequence was subjected to homology searches through BLAST software against the GenBank and EBI databases. ClustalW was used to align the multiple sequences for comparison.
Results
Culture and Morphology
The fungal isolates were subjected to routine microbiological culture on blood agar and SDA plates. After 48 h of incubation, small, pale cream-coloured colonies were visible on the SDA plates grown at 37°C. Some of the colonies were smooth at the surfaces while others appeared slightly wrinkled. The reverse colony was also pale cream coloured. No growth was observed on the plate that was incubated at 42°C. When inoculated into SDB, no growth is observed on the surface of the liquid. Microscopy examination of the cells showed blastospores with elongated pseudohyphae. Along pseudohyphae, blastospores sometimes sprouted randomly. Occasionally, giant cells which are a mass of mycelia were seen. We evaluated the sugar assimilation profiles of the isolates using the API 20C kit. This kit identified the species as C. parapsilosis.
PCR and DNA Sequencing PCR using the universal fungal primers successfully produced the distinct bands for each isolate. The size of the fragments was approximately 500 bp as shown in Fig. 1 . Figure 2 shows the reamplified amplicons that were subsequently purified from the agarose gel and sequenced to verify the identity. Both isolates were sequenced on both strands of DNA using forward and reverse primers, and the complementary sequences were compared and edited when there were ambiguities between the sense and antisense strands, using the electropherograms as a guide. Through BLAST homology search with the unedited sequences (513 nts and 499 nts respectively for UPMCor01 and UPMCor02), it was revealed that the sequences were 99% identical to one particular GenBank entry, namely the nucleotide sequence of the C. orthopsilosis strain MCO456 18S ribosomal RNA gene (partial sequence); internal transcribed spacer 1, 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence and 28S ribosomal RNA gene, partial sequence [GenBank accession number AY391846.1]. The expect (E) value for the similarity was 0.0, indicating that this is non-random and highly statistically significant.
When the sequences were trimmed to 413 nucleotides to remove the ambiguous sequences at both extreme ends of the PCR products that arose due to the inherent limitation of the DNA sequencing method, the BLAST search results produced 100% identity with the C. orthopsilosis ribosomal RNA gene. The sequences for the two clinical isolates UPMCor01 and UPMCor02 were aligned with that of the C. orthopsilosis strain MCO456 using CLU-STALW and this is displayed in Fig. 3 . Both the UPMCor01 and UPMCor02 isolates were identical to each other and also to the GenBank isolate within the ribosomal gene sequenced except for a few nucleotides at both extreme ends (Table 1) . UPMCor02 has a single nucleotide variation of A to C at position 26 which is within the internal transcribed spacer 1 (ITS1) region, compared to UPMCor02 and strain MCO456. Both the UPMCor01 and UPMCor02 sequences have been submitted to GenBank and accorded accession numbers EU247754 and EU247755 respectively.
Discussion
Three groups of C. parapsilosis strains have previously been recognized, as group I, II or III on the basis of molecular fingerprinting. Group I strains (which include the type strain CLIB214, synonymous with ATCC 22019) are predominant in clinical isolates. Subsequently, studies on the levels of heterozygosity and on the linear and circular forms of mitochondrial genomes in C. parapsilosis subgroups favoured the hypothesis that the three groups were actually three different species [6] . In 2005, based on sequencing analysis of various genes, group II and group III isolates have been reclassified as a new species, separate from C. parapsilosis [7] .
Historically, restriction fragment polymorphisms showed that C. parapsilosis isolates were more Fig. 1 Gel electrophoresis of PCR products amplified from blood culture isolates UPMCor01 and UPMCor02 using ITS1 and ITS4 primers. Lane M-100 bp DNA ladder (Fermentas), Lane 1-PCR product from isolate UPMCor01, Lane 2-PCR product from isolates UPMCor02 Fig. 2 Gel electrophoresis of re-amplified PCR products from isolates UPMCor01 and UPMCor2. Lanes: 100bp-100 bp DNA ladder (Fermentas), Lanes 1-re-amplified amplicons from UPMCor1, Lanes 2-reamplified amplicons from UPMCor02 genotypically heterogeneous than other Candida species [8] . C. parapsilosis isolates can be classified into three groups which can be distinguished on the basis of randomly amplified polymorphic DNA (RAPD) [9] , multilocus enzyme electrophoresis [10] , internal transcribed spacer (ITS) sequences of [10] . However, when Tavanthi and co researchers (2005) determined the nucleotide sequences of four different genes of paired isolates of C. parapsilosis groups I, II and III, they found the genotypic differences among the isolates between the groups to be too different to warrant their classification as subgroups within a species. It was shown that the strains had ITS1 sequence similarity of 82.5% (group I versus group III), 88.1% (group I versus group II), and 86.1% (group II versus group III). The intergroup DNA sequence similarities ranged from 82.5 to 86.6%. Hence, C. parapsilosis group II was renamed C. orthopsilosis, and C. parapsilosis group III was named as C. metapsilosis. Candida orthopsilosis, or previously known as C. parapsilosis Group II, is a close relative of C. parapsilosis. Morphologically and phenotypically, C. orthopsilosis cannot be distinguished from C. parapsilosis. The criterion of morphology and phenotypic characteristics coupled with biochemical function that tests the ability of microorganisms to assimilate different sugar compounds has been highly debatable. Through molecular phylogenetic analyses based on DNA sequence data, many traditional concepts of species delineation have been revamped to a great extent. For instance, among fungal pathogens, molecular phylogenies form the basis for differentiating Candida dubliniensis from C. albicans [11] , where the former has been consistently mislabelled as C. albicans for decades. Subsequently, a reliable phenotypic test to distinguish the two species based on their different capability to grow at a higher temperature of 42°C was finally established after many years [12] . Another example is Coccidioides posadasii and Coccidioides immitis [13] , although phenotypic differentiation of these two species has not yet been developed.
In terms of its clinical significance, C. parapsilosis is now the second most commonly isolated Candida species from blood cultures in Europe, Canada and Latin America and in some European hospitals even outranks C. albicans [14] [15] [16] . It is responsible for 24% of Candida infections in children less than 1-year-old [17] [18] [19] . Unlike other Candida species, C. parapsilosis has been found on the hands of health care workers, resulting in subsequent nosocomial infection associated with handling central venous catheters [20, 21] . C. parapsilosis is particularly problematic since it is able to grow as biofilms on implanted medical devices, conferring almost total resistance to antifungal drugs; as compared to the inability of C. orthopsilosis and C. metapsilosis isolates (referred to as groups II and III C. parapsilosis in this study) [22] . The ability to grow as a biofilm is directly related to clinically significant disease, which is an important characteristic of C. parapsilosis [23] .
This is the first report of the isolation of a C. orthopsilosis strain in Asia. In the study by Tavanthi and others, the C. orthopsilosis isolates (C. parapsilosis group II isolates) were obtained from various body sites and medical devices, such as vagina (1), nail (1), blood (3) and central venous pressure catheter (1) in United States and Europe. Prior to being classified as a new species, the clinical significance of C. orthopsilosis is not known. Therefore, more investigations need to be carried out to study its virulence properties in comparison to its close cousin, C. parapsilosis. A further insight from the result is that many of the so-called C. parapsilosis type strains in established culture collections may not be C. parapsilosis after all, and an initiative has to be carried out to recharacterize and recategorize these strains.
